David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.91% |
| 2 | Technology | 15.8% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Healthcare | 10.16% |
| 5 | Financials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Lindsay Corp
LNN
$1.15B
| $2.23M | ﹤0.01% |
23,278
+1,729
| +8% | +$158K |
|
2327
PUT
AMC Global Media
AMCX
$516M
| $2.22M | ﹤0.01% |
56,200
+29,400
| +110% | +$1.23M |
|
|
ECHO
2328
EchoStar
ECHO
$24.8B
| $2.22M | ﹤0.01% |
51,180
-97,006
| -65% | -$3.89M |
|
2329
Cheniere Energy
LNG
$57.9B
| $2.22M | ﹤0.01% |
36,282
+7,378
| +26% | +$454K |
|
|
TUP
2330
DELISTED
Tupperware Brands Corporation
TUP
| $2.21M | ﹤0.01% |
258,022
-659,304
| -72% | -$7.19M |
|
2331
CALL
Dover
DOV
$27.3B
| $2.21M | ﹤0.01% |
+19,200
| New | +$2.06M |
|
2332
Live Oak Bancshares
LOB
$1.84B
| $2.21M | ﹤0.01% |
116,372
+12,828
| +12% | +$237K |
|
2333
PUT
Forrester Research
FORR
$235M
| $2.21M | ﹤0.01% |
53,000
| – | – |
|
|
OSB
2334
DELISTED
Norbord Inc.
OSB
| $2.21M | ﹤0.01% |
+82,610
| New | +$2.2M |
|
2335
Cigna
CI
$73.9B
| $2.21M | ﹤0.01% |
10,786
-72,518
| -87% | -$13.3M |
|
|
ADVM
2336
DELISTED
Adverum Biotechnologies
ADVM
| $2.2M | ﹤0.01% |
19,116
-3,827
| -17% | -$337K |
|
2337
Orion Group Holdings
ORN
$386M
| $2.2M | ﹤0.01% |
424,226
+141,644
| +50% | +$703K |
|
2338
CALL
AppFolio
APPF
$8.15B
| $2.2M | ﹤0.01% |
+20,000
| New | +$2.04M |
|
2339
Ingles Markets
IMKTA
$1.57B
| $2.19M | ﹤0.01% |
46,206
-15,986
| -26% | -$681K |
|
|
JWN
2340
CALL
DELISTED
Nordstrom
JWN
| $2.19M | ﹤0.01% |
53,500
-32,000
| -37% | -$1.18M |
|
2341
PUT
Johnson & Johnson
JNJ
$643B
| $2.19M | ﹤0.01% |
15,000
-20,000
| -57% | -$2.71M |
|
2342
CALL
Ventas
VTR
$47.7B
| $2.19M | ﹤0.01% |
37,900
-33,800
| -47% | -$2.12M |
|
2343
Universal Health Services
UHS
$10.3B
| $2.19M | ﹤0.01% |
15,232
-10,068
| -40% | -$1.44M |
|
|
RAVN
2344
DELISTED
Raven Industries Inc
RAVN
| $2.19M | ﹤0.01% |
63,412
+35,844
| +130% | +$1.22M |
|
2345
CryoPort
CYRX
$840M
| $2.18M | ﹤0.01% |
132,664
-118,671
| -47% | -$1.77M |
|
|
FMBI
2346
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $2.18M | ﹤0.01% |
94,691
-142,044
| -60% | -$3.02M |
|
|
JAG
2347
DELISTED
Jagged Peak Energy Inc.
JAG
| $2.18M | ﹤0.01% |
+257,014
| New | +$1.88M |
|
2348
Matrix Service
MTRX
$304M
| $2.18M | ﹤0.01% |
95,228
-131,109
| -58% | -$2.59M |
|
|
BHVN
2349
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.18M | ﹤0.01% |
40,000
+10,000
| +33% | +$495K |
|
2350
ACI Worldwide
ACIW
$5.41B
| $2.18M | ﹤0.01% |
57,470
-57,201
| -50% | -$1.95M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.91B in Q4 2019, closing 412 positions and reducing 1,498 holdings. Its most notable exit was Celgene Corp, an estimated $460M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Tesla worth $501M.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.